Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle
- PMID: 1964579
- DOI: 10.1007/BF01856509
Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle
Abstract
A newly synthesized 1,3-thiazole derivative ZSY-39 increased the force of contraction in a concentration-dependent manner in association with elevation of tissue cyclic AMP levels in the isolated canine ventricular trabeculae electrically driven at 0.5 Hz at 37 degrees C. ZSY-39 shortened the duration of isometric contractions mainly by abbreviation of the relaxation time. The maximal response to and EC50 of ZSY-39 were 0.7 (isoproterenol = 1.0) and 4.6 x 10(-5) M. Bupranolol (3 x 10(-7) M) did not affect the positive inotropic effect of ZSY-39. The time course of increases in the force of contraction induced by ZSY-39 (10(-4) M) coincided with that of cyclic AMP accumulation. The concentration-response curve for the increase in the force of contraction produced by ZSY-39 was superimposable on that of the elevation of cyclic AMP levels. Carbachol (3 x 10(-6) M) shifted the concentration-response curve for the increase in force by ZSY-39 to the right and downward, and decreased the accumulation of cyclic AMP induced by ZSY-39 (10(-4) M). ZSY-39 (10(-5) M) enhanced significantly the positive inotropic effect of isoproterenol. The relationship between the force of contraction and cyclic AMP levels after the administration of ZSY-39 was not modified by the addition of carbachol or isoproterenol. These findings indicate that cyclic AMP plays an important role in the positive inotropic effect of ZSY-39 on canine ventricular muscle.
Similar articles
-
Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle.Jpn J Pharmacol. 1990 Feb;52(2):215-24. doi: 10.1254/jjp.52.215. Jpn J Pharmacol. 1990. PMID: 2156096
-
Subcellular mechanism of the positive inotropic effect of a new quinolinone derivative OPC-8490 on the dog ventricular myocardium.Heart Vessels. 1991;6(3):158-67. doi: 10.1007/BF02058281. Heart Vessels. 1991. PMID: 1655692
-
Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium.J Cardiovasc Pharmacol. 1991 Mar;17(3):365-75. doi: 10.1097/00005344-199103000-00003. J Cardiovasc Pharmacol. 1991. PMID: 1711596
-
Studies on the mechanism of action of the bipyridine milrinone on the heart.Basic Res Cardiol. 1989;84 Suppl 1:85-103. doi: 10.1007/BF02650349. Basic Res Cardiol. 1989. PMID: 2554875 Review.
-
New positive inotropic agents acting by phosphodiesterase inhibition or alpha 1-adrenergic stimulation.Pharmacol Res. 1989 Jul-Aug;21(4):329-37. doi: 10.1016/1043-6618(89)90150-3. Pharmacol Res. 1989. PMID: 2570416 Review.